Brinker Capital’s Amedisys AMED Stock Holding History

Brinker Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,151	Closed	-$211K	–	934
2020 Q1	$211K	Buy	+1,151	New	+$205K	0.01%	852
2019 Q2	–	Sell	-1,857	Closed	-$229K	–	934
2019 Q1	$229K	Buy	+1,857	New	+$233K	0.01%	863

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Brinker Capital's AMED Position: Q2 2020 in Review

Brinker Capital sold out of Amedisys (AMED) in Q2 2020, closing a stake of 1,151 shares — an estimated $211K sold.

Brinker Capital first reported a position in AMED in Q1 2019 and held it in 2 quarters. The position peaked at $229K in Q1 2019. 355 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

Brinker Capital reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
Brinker Capital sold 1,151 Amedisys shares in Q2 2020, an estimated $211K.
Brinker Capital first reported a position in Amedisys in Q1 2019 and held it in 2 quarters.
Brinker Capital's Amedisys position peaked at $229K in Q1 2019.
355 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.